X

pharma

BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results

Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to…

Infographic: How Tilray (TLRY) performed in Q1 2022

Tilray (NASDAQ: TLRY) reported first-quarter 2022 financial results after the regular market hours on Thursday. Total net revenue increased 43%…